首页> 外国专利> In the medicine which possesses the medicine content constituent null rechinoin

In the medicine which possesses the medicine content constituent null rechinoin

机译:在具有药物含量成分的药物中无效的蛋黄素

摘要

PROBLEM TO BE SOLVED: To obtain a composition stable in the solution or in the dissolution state of a medicine having a retinoic acid receptor agonist effect.;SOLUTION: This composition is obtained by mixing poly (ethylene glycol), a basic additive and water with a medicine having a retinoic acid receptor agonist effect. The example of the above medicine is 4-[2-{5-(7-fluoro-4- trifluoromethylbenzofran-2-yl)pyrrolyl}]benzoic acid shown in formula 1 or etretinate expressed by formula 2. As the basic additive, a carboxylate such as sodium acetate and an inorganic salt such as sodium hydroxide are exemplified.;COPYRIGHT: (C)2002,JPO
机译:解决的问题:为了获得在溶液中或在具有视黄酸受体激动剂作用的药物的溶解状态下稳定的组合物;解决方案:该组合物是通过将聚(乙二醇),一种碱性添加剂和水与具有视黄酸受体激动剂作用的药物。上述药物的实例是式1所示的4- [2- {5-(7-氟-4-三氟甲基苯并呋喃-2-基)吡咯基}]苯甲酸或式2表示的依维酸酯。作为基本添加剂,a以羧酸盐如乙酸钠和无机盐如氢氧化钠为例。版权所有:(C)2002,JPO

著录项

  • 公开/公告号JP4061015B2

    专利类型

  • 公开/公告日2008-03-12

    原文格式PDF

  • 申请/专利号JP20000329938

  • 发明设计人 鈴木 康之;

    申请日2000-10-30

  • 分类号A61K31/40;A61K47/00;A61K47/04;A61K47/12;A61K47/34;A61P3/06;A61P3/10;A61P9/00;A61P13/00;A61P13/12;A61P15/00;A61P17/00;A61P19/00;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P29/00;A61P31/00;A61P35/00;A61P35/02;A61P37/02;A61P43/00;C07D405/04;

  • 国家 JP

  • 入库时间 2022-08-21 20:19:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号